rs3948463

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080424.4(SP110):​c.1737G>A​(p.Met579Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0674 in 1,611,874 control chromosomes in the GnomAD database, including 4,258 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.053 ( 301 hom., cov: 33)
Exomes 𝑓: 0.069 ( 3957 hom. )

Consequence

SP110
NM_080424.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.229

Publications

18 publications found
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP110 Gene-Disease associations (from GenCC):
  • hepatic veno-occlusive disease-immunodeficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022109747).
BP6
Variant 2-230172144-C-T is Benign according to our data. Variant chr2-230172144-C-T is described in ClinVar as Benign. ClinVar VariationId is 334897.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.078 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_080424.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
NM_080424.4
MANE Select
c.1737G>Ap.Met579Ile
missense
Exon 16 of 19NP_536349.3Q9HB58-6
SP110
NM_001378442.1
c.1755G>Ap.Met585Ile
missense
Exon 17 of 20NP_001365371.1
SP110
NM_001378443.1
c.1737G>Ap.Met579Ile
missense
Exon 16 of 19NP_001365372.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
ENST00000258381.11
TSL:2 MANE Select
c.1737G>Ap.Met579Ile
missense
Exon 16 of 19ENSP00000258381.6Q9HB58-6
SP110
ENST00000358662.9
TSL:1
c.1737G>Ap.Met579Ile
missense
Exon 16 of 18ENSP00000351488.4Q9HB58-1
SP110
ENST00000897327.1
c.1737G>Ap.Met579Ile
missense
Exon 17 of 19ENSP00000567386.1

Frequencies

GnomAD3 genomes
AF:
0.0531
AC:
8089
AN:
152208
Hom.:
301
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0131
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.0521
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.0538
Gnomad FIN
AF:
0.0339
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0797
Gnomad OTH
AF:
0.0632
GnomAD2 exomes
AF:
0.0599
AC:
15056
AN:
251380
AF XY:
0.0620
show subpopulations
Gnomad AFR exome
AF:
0.0127
Gnomad AMR exome
AF:
0.0357
Gnomad ASJ exome
AF:
0.146
Gnomad EAS exome
AF:
0.00299
Gnomad FIN exome
AF:
0.0315
Gnomad NFE exome
AF:
0.0818
Gnomad OTH exome
AF:
0.0740
GnomAD4 exome
AF:
0.0689
AC:
100601
AN:
1459548
Hom.:
3957
Cov.:
30
AF XY:
0.0690
AC XY:
50146
AN XY:
726272
show subpopulations
African (AFR)
AF:
0.0125
AC:
419
AN:
33448
American (AMR)
AF:
0.0383
AC:
1715
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.145
AC:
3795
AN:
26120
East Asian (EAS)
AF:
0.00159
AC:
63
AN:
39680
South Asian (SAS)
AF:
0.0525
AC:
4527
AN:
86222
European-Finnish (FIN)
AF:
0.0330
AC:
1763
AN:
53414
Middle Eastern (MID)
AF:
0.0866
AC:
499
AN:
5760
European-Non Finnish (NFE)
AF:
0.0755
AC:
83770
AN:
1109846
Other (OTH)
AF:
0.0671
AC:
4050
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
4459
8918
13377
17836
22295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2976
5952
8928
11904
14880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0531
AC:
8082
AN:
152326
Hom.:
301
Cov.:
33
AF XY:
0.0508
AC XY:
3783
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0131
AC:
545
AN:
41582
American (AMR)
AF:
0.0520
AC:
796
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
473
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5182
South Asian (SAS)
AF:
0.0528
AC:
255
AN:
4830
European-Finnish (FIN)
AF:
0.0339
AC:
360
AN:
10618
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0797
AC:
5424
AN:
68026
Other (OTH)
AF:
0.0625
AC:
132
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
380
760
1140
1520
1900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0716
Hom.:
1399
Bravo
AF:
0.0522
TwinsUK
AF:
0.0709
AC:
263
ALSPAC
AF:
0.0721
AC:
278
ESP6500AA
AF:
0.0168
AC:
74
ESP6500EA
AF:
0.0826
AC:
710
ExAC
AF:
0.0606
AC:
7353
Asia WGS
AF:
0.0280
AC:
97
AN:
3478
EpiCase
AF:
0.0806
EpiControl
AF:
0.0835

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hepatic veno-occlusive disease-immunodeficiency syndrome (2)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
8.1
DANN
Benign
0.64
DEOGEN2
Benign
0.0048
T
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.095
N
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.84
L
PhyloP100
-0.23
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.96
N
REVEL
Benign
0.16
Sift
Benign
0.48
T
Sift4G
Benign
0.43
T
Polyphen
0.046
B
Vest4
0.094
MutPred
0.77
Gain of methylation at K580 (P = 0.0439)
MPC
0.16
ClinPred
0.00030
T
GERP RS
2.7
Varity_R
0.065
gMVP
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3948463; hg19: chr2-231036860; COSMIC: COSV51250701; COSMIC: COSV51250701; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.